scholarly journals QT dispersion and prognosis after coronary stent placement in acute myocardial infarction

2007 ◽  
Vol 30 (5) ◽  
pp. 229-233 ◽  
Author(s):  
Hiroyasu Ueda, ◽  
Tomoshige Hayashi, ◽  
Kei Tsumura, ◽  
Kazuaki Kaitani, ◽  
Kiyomichi Yoshimaru, ◽  
...  
2006 ◽  
Vol 111 (2) ◽  
pp. 286-291 ◽  
Author(s):  
Hiroyasu Ueda ◽  
Tomoshige Hayashi ◽  
Kei Tsumura ◽  
Kiyomichi Yoshimaru ◽  
Yasunori Nakayama ◽  
...  

2001 ◽  
Vol 80 (1) ◽  
pp. 37-45 ◽  
Author(s):  
Vicent Bodı́ ◽  
Juan Sanchis ◽  
Alejandro Navarro ◽  
Eva Plancha ◽  
Francisco J Chorro ◽  
...  

Open Medicine ◽  
2008 ◽  
Vol 3 (2) ◽  
pp. 179-182 ◽  
Author(s):  
Mohammad Ostovan ◽  
Shahdad Khosropanah ◽  
Shohreh Hooshmand

AbstractThe 12-lead surface electrocardiogram adjacent QTc dispersion, which is the maximum difference of corrected QT interval between two adjacent leads, is a simple method to determine regional variation in repolarization and refractoriness. The aim of this study is to evaluate adjacent QTc dispersion as a marker of susceptibility to ventricular arrhythmias after myocardial infarction. A total of 135 consecutive patients with acute myocardial infarction were enrolled in the study. Adjacent QTc, measured by lens magnifier, was calculated on the first, second and third days after acute myocardial infarction. On the second day after acute myocardial infarction, adjacent QTc dispersion was significantly greater in patients with ventricular arrhythmias (P < 0.001). Adjacent QTc dispersion on the first and fifth day after acute myocardial infarction was not associated with development of ventricular arrhythmias. On the second day after acute myocardial infarction, adjacent QTc dispersion is a simple and feasible method for prediction of ventricular arrhythmias.


2021 ◽  
pp. 1-4
Author(s):  
Sadeq Tabatabai ◽  
Nooshin Bazargani ◽  
Kamaleldin Al-Tahmody ◽  
Jasem Mohammed Alhashmi

Soon after it was discovered in Wuhan, China, in December 2019, coronavirus disease 2019 (COVID-19) blow-out very fast and became a pandemic. The usual presentation is respiratory tract infection, but cardiovascular system involvement is sometimes fatal and also a serious personal and health care burden. We report a case of a 57-year-old man who was admitted with anterior wall acute myocardial infarction secondary to early coronary stent thrombosis and associated with COVID-19 infection. He was managed with primary coronary angioplasty and discharged home. Procoagulant and hypercoagulability status associated with severe acute respiratory syndrome coronavirus 2 infection is the most likely culprit. Choosing aggressive antithrombotic agents after coronary angioplasty to prevent stent thrombosis during the COVID-19 pandemic may be the answer but could be challenging.


Sign in / Sign up

Export Citation Format

Share Document